Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Deciphera Pharmaceuticals (DCPH) Short Interest Ratio & Short Volume

Deciphera Pharmaceuticals logo

Deciphera Pharmaceuticals Short Interest Data

Deciphera Pharmaceuticals (DCPH) has a short interest of 3.17 million shares, representing 5.71% of the float (the number of shares available for trading by the public). This marks a -19.13% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 1.29 million shares to cover all short positions.

Current Short Interest
3,170,000 shares
Previous Short Interest
3,920,000 shares
Change Vs. Previous Month
-19.13%
Dollar Volume Sold Short
$80.96 million
Short Interest Ratio
1.7 Days to Cover
Last Record Date
May 31, 2024
Outstanding Shares
86,476,000 shares
Float Size
55,520,000 shares
Short Percent of Float
5.71%
Today's Trading Volume
600 shares
Average Trading Volume
1,292,551 shares
Today's Volume Vs. Average
0%
Short Selling Deciphera Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Deciphera Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

DCPH Short Interest Over Time

DCPH Days to Cover Over Time

DCPH Percentage of Float Shorted Over Time

Deciphera Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/20243,170,000 shares $80.96 million -19.1%5.7%1.7 $25.54
5/15/20243,920,000 shares $99.76 million -33.0%7.3%2.3 $25.45
4/30/20245,850,000 shares $147.83 million +1.7%11.7%3.8 $25.27
4/15/20245,750,000 shares $85.68 million -5.1%11.5%10.9 $14.90
3/31/20246,060,000 shares $95.32 million +7.3%12.3%11.2 $15.73
3/15/20245,650,000 shares $88.08 million +2.5%11.4%10.6 $15.59
2/29/20245,510,000 shares $91.96 million No Change11.2%9.8 $16.69
2/15/20245,510,000 shares $87.72 million +3.2%11.2%10 $15.92
1/31/20245,340,000 shares $76.47 million +7.4%10.9%9.6 $14.32
1/15/20244,970,000 shares $73.75 million +1.2%10.2%7.5 $14.84
12/31/20234,910,000 shares $79.20 million +0.4%10.1%6.9 $16.13
12/15/20234,890,000 shares $78.00 million -15.0%10.1%6.8 $15.95
11/30/20235,750,000 shares $72.51 million +3.6%11.9%8.2 $12.61
11/15/20235,550,000 shares $68.49 million +41.9%11.5%8.6 $12.34
10/31/20233,910,000 shares $46.88 million -3.0%8.1%6 $11.99
10/15/20234,030,000 shares $44.13 million -0.3%8.5%7.9 $10.95
9/30/20234,040,000 shares $51.39 million -7.1%8.5%8.6 $12.72
9/15/20234,350,000 shares $58.38 million +2.4%9.1%10.6 $13.42
8/31/20234,250,000 shares $59.67 million +4.2%7.8%9.9 $14.04
8/15/20234,080,000 shares $63.16 million -1.0%7.5%9.1 $15.48
7/31/20234,120,000 shares $55.70 million +6.5%7.6%9.3 $13.52
7/15/20233,870,000 shares $54.22 million +2.1%7.1%7.8 $14.01
6/30/20233,790,000 shares $53.36 million -14.1%6.7%7.1 $14.08
6/15/20234,410,000 shares $64.12 million +2.3%8.1%7.9 $14.54
5/31/20234,310,000 shares $58.19 million +14.9%8.0%6.9 $13.50
5/15/20233,750,000 shares $53.33 million +11.0%7.0%5.8 $14.22
4/30/20233,380,000 shares $48.03 million +0.3%6.3%4.9 $14.21
4/15/20233,370,000 shares $49.00 million -40.9%6.5%4.5 $14.54
3/31/20235,700,000 shares $88.07 million +6.9%11.0%7.1 $15.45
3/15/20235,330,000 shares $89.22 million -0.7%10.3%6.3 $16.74
2/28/20235,370,000 shares $77.87 million No Change10.3%6.9 $14.50
2/15/20235,370,000 shares $83.13 million +7.6%10.4%7.1 $15.48
1/31/20234,990,000 shares $84.88 million +4.8%10.8%6.9 $17.01
1/15/20234,760,000 shares $102.34 million -33.7%10.0%7 $21.50
12/30/20227,180,000 shares $117.68 million -6.5%15.1%12.4 $16.39
12/15/20227,680,000 shares $120.58 million +7.7%16.1%13.9 $15.70
11/30/20227,130,000 shares $113.44 million -2.9%15.0%11 $15.91
11/15/20227,340,000 shares $115.53 million +2.4%15.5%10.4 $15.74
10/31/20227,170,000 shares $116.30 million -2.9%15.1%9.4 $16.22
10/15/20227,380,000 shares $123.47 million -1.9%15.7%9.1 $16.73
Download Our Tesla Ebook For Free (Ad)

Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.
9/30/20227,520,000 shares $139.12 million +0.8%16.0%8.9 $18.50
9/15/20227,460,000 shares $147.86 million -5.1%15.9%8.4 $19.82
8/31/20227,860,000 shares $127.57 million +9.6%16.8%8.4 $16.23
8/15/20227,170,000 shares $119.31 million +1.7%15.3%7.6 $16.64
7/31/20227,050,000 shares $89.46 million +2.0%15.2%6.8 $12.69
7/15/20226,910,000 shares $89.90 million -3.6%14.9%5.9 $13.01
6/30/20227,170,000 shares $94.29 million -0.8%15.5%5.8 $13.15
6/15/20227,230,000 shares $84.01 million +7.8%15.6%6 $11.62
5/31/20226,710,000 shares $72.74 million -11.1%14.5%5.4 $10.84
5/15/20227,550,000 shares $77.84 million +11.4%16.3%5.8 $10.31
4/30/20226,780,000 shares $68.61 million -6.1%16.1%5 $10.12
4/15/20227,220,000 shares $75.45 million +10.7%18.0%5.7 $10.45
3/31/20226,520,000 shares $60.44 million -6.9%N/A5.1 $9.27
3/15/20227,000,000 shares $54.04 million -3.6%17.4%4.5 $7.72
2/28/20227,260,000 shares $55.97 million +10.5%18.1%4.3 $7.71
2/15/20226,570,000 shares $62.09 million +0.6%16.4%3.5 $9.45
1/31/20226,530,000 shares $55.05 million +4.5%17.5%3 $8.43
1/15/20226,250,000 shares $55.44 million +0.5%N/A2.5 $8.87
12/31/20216,220,000 shares $60.77 million +44.7%16.6%2.6 $9.77
12/15/20214,300,000 shares $39.69 million +51.9%11.5%2.1 $9.23
11/30/20212,830,000 shares $24.42 million +36.1%7.6%1.7 $8.63
11/15/20212,080,000 shares $19.22 million -15.5%5.6%1.5 $9.24
10/29/20212,460,000 shares $82.14 million +5.6%6.8%2.2 $33.39
10/15/20212,330,000 shares $81.15 million -10.0%6.5%6.4 $34.83
9/30/20212,590,000 shares $88.01 million +0.8%7.2%7.4 $33.98
9/15/20212,570,000 shares $79.77 million -7.6%7.1%7.5 $31.04
8/31/20212,780,000 shares $87.57 million -2.1%7.7%8.1 $31.50
8/13/20212,840,000 shares $80.37 million -2.4%7.5%7.9 $28.30
7/30/20212,910,000 shares $88.73 million -2.4%7.7%7.7 $30.49
7/15/20212,980,000 shares $100.58 million -4.8%7.6%7.5 $33.75
6/30/20213,130,000 shares $114.59 million -1.6%8.0%7.3 $36.61
6/15/20213,180,000 shares $114.10 million -2.8%8.1%7.5 $35.88
5/28/20213,270,000 shares $110.33 million -16.2%8.3%7.8 $33.74
5/14/20213,900,000 shares $127.65 million -8.2%N/A9 $32.73
4/30/20214,250,000 shares $198.82 million +6.5%N/A9.3 $46.78
4/15/20213,990,000 shares $183.38 million +5.0%N/A8.9 $45.96
3/31/20213,800,000 shares $157.81 million +10.5%N/A8.6 $41.53
3/15/20213,440,000 shares $148.33 million +4.6%N/A7.6 $43.12
2/26/20213,290,000 shares $140.12 million +21.4%N/A7.3 $42.59
2/12/20212,710,000 shares $134.77 million -15.3%N/A6.3 $49.73
1/29/20213,200,000 shares $142.85 million -11.4%N/A8.2 $44.64
1/15/20213,610,000 shares $184.72 million No ChangeN/A9.8 $51.17
12/31/20203,610,000 shares $210.07 million -3.5%N/A10.7 $58.19
12/15/20203,740,000 shares $213.11 million +3.6%N/A10.6 $56.98
11/30/20203,610,000 shares $225.08 million -5.0%N/A9.7 $62.35
11/15/20203,800,000 shares $247.34 million No Change10.0%10.6 $65.09
10/30/20203,800,000 shares $224.09 million -5.5%10.0%11.1 $58.97
10/15/20204,020,000 shares $225.28 million -3.8%10.7%11.1 $56.04
9/30/20204,180,000 shares $214.43 million +10.6%11.1%11.4 $51.30
9/15/20203,780,000 shares $194.63 million -5.3%10.0%9.2 $51.49
Download Our Tesla Ebook For Free (Ad)

Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.
8/31/20203,990,000 shares $179.59 million -6.1%10.6%9.4 $45.01
8/14/20204,250,000 shares $192.40 million -0.9%11.3%9.7 $45.27
7/31/20204,290,000 shares $198.93 million -0.9%11.7%9.1 $46.37
7/15/20204,330,000 shares $227.15 million -1.6%11.9%8.5 $52.46
6/30/20204,400,000 shares $257.53 million +25.0%12.1%8.3 $58.53
6/15/20203,520,000 shares $206.41 million +12.1%9.7%6.8 $58.64
5/29/20203,140,000 shares $183.91 million +11.0%8.6%5.4 $58.57
5/15/20202,830,000 shares $137.17 million -5.0%7.8%4.7 $48.47
4/30/20202,980,000 shares $172.78 million +2.1%8.2%4.6 $57.98
4/15/20202,920,000 shares $127.37 million -4.6%8.1%4.9 $43.62
3/31/20203,060,000 shares $146.94 million +17.2%8.4%4.9 $48.02
3/13/20202,610,800 shares $113.10 million -8.1%7.5%3.8 $43.32
2/28/20202,840,000 shares $103.69 million -4.7%8.1%4.8 $36.51
2/14/20202,980,000 shares $148.97 million +16.4%8.9%5.3 $49.99
1/31/20202,560,000 shares $139.34 million -3.0%8.2%4.8 $54.43
1/15/20202,640,000 shares $181.74 million +5.6%8.5%4.5 $68.84
12/31/20192,500,000 shares $165.63 million +7.8%8.0%4.5 $66.25

DCPH Short Interest - Frequently Asked Questions

What is Deciphera Pharmaceuticals' current short interest?

Short interest is the volume of Deciphera Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 3,170,000 shares of DCPH short. 5.71% of Deciphera Pharmaceuticals' shares are currently sold short. Learn More on Deciphera Pharmaceuticals' current short interest.

What is a good short interest ratio for Deciphera Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DCPH shares currently have a short interest ratio of 2.0. Learn More on Deciphera Pharmaceuticals's short interest ratio.

What is a good short interest percentage for Deciphera Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.71% of Deciphera Pharmaceuticals' floating shares are currently sold short.

Is Deciphera Pharmaceuticals' short interest increasing or decreasing?

Deciphera Pharmaceuticals saw a drop in short interest during the month of May. As of May 31st, there was short interest totaling 3,170,000 shares, a drop of 19.1% from the previous total of 3,920,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Deciphera Pharmaceuticals' float size?

Deciphera Pharmaceuticals currently has issued a total of 86,476,000 shares. Some of Deciphera Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Deciphera Pharmaceuticals currently has a public float of 55,520,000 shares.

How does Deciphera Pharmaceuticals' short interest compare to its competitors?

5.71% of Deciphera Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Deciphera Pharmaceuticals: Xencor, Inc. (7.16%), Syndax Pharmaceuticals, Inc. (12.49%), Seres Therapeutics, Inc. (10.45%), Roivant Sciences Ltd. (12.38%), Ascendis Pharma A/S (5.62%), Legend Biotech Co. (8.70%), Elanco Animal Health Incorporated (2.81%), Blueprint Medicines Co. (6.50%), Lantheus Holdings, Inc. (6.03%), Nuvalent, Inc. (12.72%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks.

What does it mean to sell short Deciphera Pharmaceuticals stock?

Short selling DCPH is an investing strategy that aims to generate trading profit from Deciphera Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Deciphera Pharmaceuticals?

A short squeeze for Deciphera Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DCPH, which in turn drives the price of the stock up even further.

How often is Deciphera Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DCPH, twice per month. The most recent reporting period available is May, 31 2024.




This page (NASDAQ:DCPH) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners